BACKGROUND: Cavernous carotid artery aneurysms can be treated by several endovascular techniques including flow diversion (FD) and parent vessel occlusion (PVO). We reviewed our institution's consecutive series of endovascularly treated cavernous carotid artery aneurysms to compare these two modalities and their associated clinical and radiographic outcomes. METHODS: All patients harboring a cavernous carotid artery aneurysm treated by FD or PVO from January 2008 to December 2018 were enrolled. Data were collected retrospectively and analyzed on patient presentation, aneurysm dimensions, treatments and related complications, rate of aneurysm occlusion, sac regression, and outcomes. RESULTS: Fourteen patients were treated with FD and 12 underwent PVO subsequent to passing a balloon test occlusion. There was no significant difference between treatment modalities in aneurysmal occlusion (97.0 ± 8.4% (FD) vs. 100% (PVO), p = 0.23), degree of sac regression (62.5 ± 16.7% (FD) vs. 56.8 ± 24.3% (PVO), p = 0.49), or near-complete to complete symptom improvement (66.7% (FD) vs. 81.8% (PVO), p = 0.62). Major complications included subarachnoid hemorrhage from aneurysmal rupture in 1 (7.1%) patient post-FD and 2 (16.7%) ischemic strokes following PVO. CONCLUSIONS: Endovascular treatment of cavernous carotid artery aneurysms by FD or PVO are both effective and safe. There is insufficient evidence to recommend one technique over the other and decision making should be individualized to the patient, their aneurysm morphology, and operator experience.
BACKGROUND: Cavernous carotid artery aneurysms can be treated by several endovascular techniques including flow diversion (FD) and parent vessel occlusion (PVO). We reviewed our institution's consecutive series of endovascularly treated cavernous carotid artery aneurysms to compare these two modalities and their associated clinical and radiographic outcomes. METHODS: All patients harboring a cavernous carotid artery aneurysm treated by FD or PVO from January 2008 to December 2018 were enrolled. Data were collected retrospectively and analyzed on patient presentation, aneurysm dimensions, treatments and related complications, rate of aneurysm occlusion, sac regression, and outcomes. RESULTS: Fourteen patients were treated with FD and 12 underwent PVO subsequent to passing a balloon test occlusion. There was no significant difference between treatment modalities in aneurysmal occlusion (97.0 ± 8.4% (FD) vs. 100% (PVO), p = 0.23), degree of sac regression (62.5 ± 16.7% (FD) vs. 56.8 ± 24.3% (PVO), p = 0.49), or near-complete to complete symptom improvement (66.7% (FD) vs. 81.8% (PVO), p = 0.62). Major complications included subarachnoid hemorrhage from aneurysmal rupture in 1 (7.1%) patient post-FD and 2 (16.7%) ischemic strokes following PVO. CONCLUSIONS: Endovascular treatment of cavernous carotid artery aneurysms by FD or PVO are both effective and safe. There is insufficient evidence to recommend one technique over the other and decision making should be individualized to the patient, their aneurysm morphology, and operator experience.
Authors: Benjamin L Brown; Demetrius Lopes; David A Miller; Rabih G Tawk; Leonardo B C Brasiliense; Andrew Ringer; Eric Sauvageau; Ciarán J Powers; Adam Arthur; Daniel Hoit; Kenneth Snyder; Adnan Siddiqui; Elad Levy; L Nelson Hopkins; Hugo Cuellar; Rafael Rodriguez-Mercado; Erol Veznedaroglu; Mandy Binning; J Mocco; Pedro Aguilar-Salinas; Alan Boulos; Junichi Yamamoto; Ricardo A Hanel Journal: J Neurosurg Date: 2015-10-16 Impact factor: 5.115
Authors: O Tanweer; E Raz; A Brunswick; D Zumofen; M Shapiro; H A Riina; M Fouladvand; T Becske; P K Nelson Journal: AJNR Am J Neuroradiol Date: 2014-08-21 Impact factor: 3.825
Authors: David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner Journal: Lancet Date: 2003-07-12 Impact factor: 79.321
Authors: Zaahir A Turfe; Waleed Brinjikji; Mohammad H Murad; Giuseppe Lanzino; Harry J Cloft; David F Kallmes Journal: J Neurointerv Surg Date: 2014-03-21 Impact factor: 5.836
Authors: Mario Zanaty; Nohra Chalouhi; Robert M Starke; Guilherme Barros; Mark Philip Saigh; Eric Winthrop Schwartz; Norman Ajiboye; Stavropoula I Tjoumakaris; David Hasan; Robert H Rosenwasser; Pascal Jabbour Journal: Stroke Date: 2014-07-22 Impact factor: 7.914
Authors: C J O'Kelly; J Spears; M Chow; J Wong; M Boulton; A Weill; R A Willinsky; M Kelly; T R Marotta Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825
Authors: Robert M Starke; Nohra Chalouhi; Muhammad S Ali; Stavropoula I Tjoumakaris; Pascal M Jabbour; L Fernando Gonzalez; Robert H Rosenwasser; Aaron S Dumont Journal: J Clin Neurosci Date: 2013-08-20 Impact factor: 1.961